| Direct Competitor Comparison | |
|---|
| BIOS | PVT1 | CVS | ESRX | Industry |
|---|
| Market Cap: | 759.03M | N/A | 72.78B | 50.58B | 64.52B |
|---|
| Employees: | 2,112 | N/A | 203,000 | 30,215 | 99.49K |
|---|
| Qtrly Rev Growth (yoy): | 0.28 | N/A | -0.00 | 1.15 | 0.11 |
|---|
| Revenue (ttm):
| 706.08M | N/A | 123.10B | 107.79B | 27.01B |
|---|
| Gross Margin (ttm): | 0.33 | N/A | 0.19 | 0.08 | 0.61 |
|---|
| EBITDA (ttm): | 36.04M | N/A | 9.36B | 6.22B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.03 | N/A | 0.06 | 0.04 | 0.16 |
|---|
| Net Income (ttm): | -13.79M | N/A | 4.06B | 1.45B | N/A |
|---|
| EPS (ttm): | 1.05 | N/A | 3.21 | 1.70 | 3.27 |
|---|
| P/E (ttm): | 12.71 | N/A | 18.51 | 36.44 | 14.20 |
|---|
| PEG (5 yr expected): | 2.27 | N/A | 1.10 | 0.87 | 0.96 |
|---|
| P/S (ttm): | 1.08 | N/A | 0.59 | 0.46 | 2.23 |
|---|
|
| Pvt1 = American HomePatient, Inc. (privately held) | | CVS = CVS Caremark Corporation | | ESRX = Express Scripts Holding Company | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.01 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | -0.01 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.02 | 85.82B | 31.52 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.01 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.02 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.02 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | -0.01 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.01 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.01 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | -0.01 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | -0.01 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | -0.01 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | -0.01 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.01 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- CVS
- Walgreen extends agreement with CVS Caremark AP Mon, May 13
- ESRX
- Analyst lifts Express Scripts rating, price target AP Mon, May 13
- ESRX
- Ahead of the Bell: Express Scripts AP Mon, May 13
- CVS
- Bashful men can buy the little blue pill online AP Mon, May 6
- CVS
- Bashful? Buy the little blue pill online AP Mon, May 6
- CVS
- Key Walgreen revenue figure rises 1.2 pct in April AP Fri, May 3
- CVS
- Key Rite Aid revenue metric falls in April AP Thu, May 2
- ESRX
- Cardinal fiscal 3Q profit climbs nearly 4 percent AP Thu, May 2
- ESRX
- CVS Caremark 1Q profit soars 23 percent AP Wed, May 1
- ESRX
- Earnings Preview: CVS Caremark posts 1Q Wednesday AP Tue, Apr 30
All Headlines for these symbols... Currency in USD. | |
|
0.09%